We will be developing an artificial intelligence (AI)-based computer-aided software to control River Blindness, Niramai, a health-tech company announced recently.
The company will leverage its innovative Thermalytix technology to detect presence of live adult worms of Onchocerciasis which causes river blindness and significant disability.
At present, the technology is being leveraged to early-stage breast cancer detection. The innovative non-invasive detection method is expected to help assess the efficacy of new drugs being developed to control the disease by killing adult worms responsible for river blindness.
Professor Dr Christopher L King, a clinical expert from the Centre for Global Health and Diseases, Cleveland, said, “Onchocerciasis, more commonly known as river blindness, is the world’s second leading infectious cause of blindness. NIRAMAI technology can be a valuable tool to detect infectious live worms in a non-invasive way and help with the global effort to eliminate this very disabling disease.”
The Bill & Melinda Gates Foundation has supported Niramai in its new endeavour.
Dr Geetha Manjunath, CEO & CTO, Niramai, said, “We are very excited to collaborate with Gates Foundation to extend the application of our innovative technique to areas other than breast cancer. Successful completion of this research project will demonstrate a breakthrough result of Thermalytix being a new way of sensing many abnormalities in human body in a non-invasive, radiation-free and accurate way, even beyond cancer!”
About half a million people are blind or visually impaired due to the disease caused by a parasitic worm living under the skin in humans.